<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 274 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page273.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=274">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 274 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 274</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=274"><img src="../thumb/274.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.2 / 18.3 / 18.4                                           2020-04 / 237
       Side effects: Freq: Anorex., paraesthes., dizzin., headache, vis. Im-  (S4) INJ. Y/20.1.1/175,176, 178, 29/20.1.1/0684.  Side effects: Hypersens./anaphylat.reacts., irrevers. ototoxic., revers
       pairm., deafn., dysgeus., abdom. pain/cramps, diarrh., naus.,vomit.,   701065-006: 100 mg/2 ml, 10x2 ml vials, R273,27  nephrotox., ac.ren.fail. often in assoc.with other nephrotox.agents,
       flatul., loose stools, dyspeps., prurit., rash, arthralg., fatig., decr.lym-  701073-002: 250 mg/2 ml, 10x2 ml vials, R529,44  ren. funct. impairm., resp.depress., musc.paralys.due to neuromusc.
       phoc. & neutroph.counts, decr.bld. bicarb.lev., incr.eosinophil count.   701079-003: 500 mg/2 ml, 10x2 ml vials, R777,63  block.act., cross.sens.with other aminoglycosid., bld.dyscras., purpura,
       Less freq: Candidias., oral candidias., vag.infect., pseudomembran.   701070-003: 1 g/4 ml, 10x5 ml vials, R1 214,30  N&V, stomatit., liv.dysfunct.signs., neurotoxic. incl. periph. neuropath./
       colit., leukopen., neutropen., allerg. reacts., angioed., anaphylact.  Dosage: Admin.by slow IVI (2-3 mins) or infus. over 30-60 mins.for   CNS effs., convuls., endotox. shock.
       react., nervousn., agitat., hypaesthes., somnol., insomn., hear. loss/  adults & in 1-2 hrs.in infts. Do not cont.for long.than 7-10 days & con-  Special precautions: Imp.ren.funct., restrict to life-threat.infects.
       impairm, tinnit., vertigo, palpit., gastrit., constip., hepatit., abnorm.  sider alternat. therapy if no improvem.within 3-5 days.  where other antimicrob.not suit., neuro-/ototox. risk with prolong.use,
       hepat.funct., Stev.-Johns. syndr, photosens., urticar., oed., malaise,   Adults & childr: 15 mg/kg bm/day in div.dos. 8-12 hrly. Max. 1,5 g/  reg.monit. advis. dur.prolong./high dos ther., concom.anti-emet. poss.
       chest pain, asthen., incr.aspart./alanine aminotransfer., incr.bld.bili-  day in adults. Neonates: load. dos. 10 mg/kg bm.follow.by 15 mg/  mask early vestibul.ototox.sympt., other concom.neuro/nephrotox.
       rub./urea/creatin., abnorm. bld.K levs. Unknown: Thrombocytopen.,   kg/day in 2 div.dos.   meds., myasth. grav., parkinsonism, condits.charact.by musc. weakn.,
                                                                             th
       haemolyt.anaem., aggress., anx., Torsades de point., dysrhythm.incl.  Contraindications: Hypersens, pregn., lactat., myasth. grav., sev.  infts., elderly, poss.foet.8  cran.nerve damage if used dur.pregn.
       ventric.tachycard., syncope, convuls., psychomot.hyperactiv., hypo-  ren.impairm., hear.impairm.  Drug interactions: Concom.ethacryn.acid/ furosemide/other ami-
       tens., anosm., parosm.pancreatit., tong. discolourat., ageus., hepat.  Side effects: Irrevers.ototoxic., ac.ren.fail., revers. nephrotox., resp.  noglycosid./vancocin/some cephalosporins may potent.nephrotoxic.
       fail poss.result.in death, fulmin.hepatit., hepat.necros., cholestat.   depress., musc.paralys., hypersens. reacts., aminoglycos.cross-  TOBRAMYCIN FRESENIUS, Fresenius Kabi [P/S]
       jaund., tox.epiderm.necrolys., eryth.multiform., myasth, grav, ac.ren.  sens., hypomagnesaem., hypocalcaem.& hypokalaem.in assoc.
       fail., ac.interstit.nephrit., ECG QT prolong.  with antineoplast.agents, anaem., purpura, convuls., vis.disturbs.,   Tobramycin sulph.
                                                                  Indications: Potent.life-threaten.suscept.RTI, various nosocomial
       Warnings and special precautions: Ser. allerg. reacts.incl.angi-  pseudomembr.colit.
       oed./anaphylax., prolong. observat. & symptomat.treatm.of allerg.  Special precautions: Pts.with part.hear.loss.  infects.& complicat./recurr. UTI usual.in combin.with anoth.antibiot.
                                                                  with Gram.-neg.activ.
       reacts.as sympt. have recurr.despite discont., poss. pseudomembr.   Warnings: Admin.separat.from other meds.  (S4) INJ. Z/20.1.1/287.
       colit.,& consid.discont.ther.if suspect., ren.impairm., myasth.grav.  701049-007: 80 mg/2 ml, 10 vials, R812,41
       sympt. exacerbat./ new onset, superinfect., congenit./ document.QT   GENTAMYCIN FRESENIUS, Fresenius Kabi [P/S]  Dosage: Admin.IM/IV over 20-60 mins.in 50-100 ml NaCl or gluc.
                                     Gentamicin sulphate.
       prolongat./other subst.known to prolong QT interv., electrol.disturbs.  sol. Dos.not to exceed 5 mg/ kg/day unless ser.lev.monit. Treatm.
       esp. hypokalaem./ hypomagnesaem., bradycard., dysrhythm., sev.  Indications: Ac./chron.UTI, sev.syst.infects., bone & soft-tiss.in-  durat.gen.not long.than 7-10 days. Not to be mix.with other meds.
                                     fects., infect.burns, RTI, eye infects.
       card.insuff., admin.1 hr.bef.or 2 hrs. aft.antacids., monit.prothromb.  Childr: 6-7,5 mg/kg/day in 3-4 equal div.dos. Dos. interv. in paed.
       time with concom. warfar., monit. concom.ciclospor.lev., alt. contra-  (S4) INJ, [P/S] L/20.1.1/162, 163, 164  pts.may vary depend.on med.condit. Ser.lev.to be monit. Premat./
                                     725862-009: 10 mg/ml, 10x2 ml amps, R119,68
       cept.dur.ther.& 7 days aft.discont., safety & effic.in pregn./lactat.&   full-term neonates 1 wk.of age or less: up to 4 mg/kg/day in
       childr.und.1 yr not est., lactose intol.  725838-019: 40 mg/ml, 10x1 ml amps R142,86  2 equal. div.dos. 12 hrly.
       Interactions: Ciclospor./digoxin/hexobarbit./ phenytoin ser.conc.  701046-003: 40 mg/ml, 10x2 ml, amps, R293,56  Adults: Ser.infects: 3 mg/kg/day admin.once dly or in 3 equal div.
       incr., antacids decr.peak ser. conc., ac.ergot.toxic.with ergot alkaloids,   Dosage: IV admin.only recomm.when IM route not permitt. Slow IV   dos.8 hrly. Life-threat.infects: Up to 5 mg/kg/day admin.once dly.or
       ser. digox. conc.poss.incr., OC’s effic.decr., poss. methotrex. absorpt.  admin./infus.over up to 2 hrs. Treatm. durat. gen.7-10 days.  in 3-4 equal.div. dos. Reduc.to 3 mg/kg/day as soon as clinic. indicat.
                                     UTI: Mod.infects: 2 mg/kg/day as sngl.dly. dos. or in 3 equal
       reduc., metabol.of non-sedat. antihistamin./ astemizole poss.inhib.
                                     dos.8 hrly. Concom.alkalis to be giv.to raise urin.Ph above 7.  Contraindications: Safety & effic.in pregn.& lactat.not est., my-
       ZITHROMAX, Pfizer [P/S]       Syst.infects: 2 mg/kg/day as sngl.dly.dos.or 3 equal dos. 8 hrly. Sev.  asthen. grav., parkinsonism, other condits. charact.by musc.weakn.
       Azithromycin.                 infects: 3 mg/kg/day as sngl.dly.dos.or in 3 equal dos.8 hrly.  Side effects: Irrevers.ototox., ac.ren.fail., ren. impairm., neurotoxic.
       Indications: Adults: Mild to mod.LRT, sinusit., uncomplic.skin & soft   Life threat.infects: Adults: Up to 5 mg/kg/ day as sngl.dly.dos.  incl.convuls., neuromusc. block. act., vis.disturbs., encephalopa-
       tiss.infects.by suscept. organ., uncomplic.genit.chlamydia trachomat.   or in 3 equal dos.8 hrly. Dos. to be reduc.to 3 mg/kg/day as soon   thy, CNS effs., mening.irrit., arachnoidit., polyradiculit., ventriculit.,
               st
       infects., as alt.to 1  line ther.of pharyngit.& tonsilit. Childr.1 yr.& over:   as clinic. indic. Childr: 3-6 mg/kg/day in 3 equal.div.dos.8 hrly. In-  bld. disords., pseudomembr.colit., hypersens. reacts., hypomag-
       Pharyngit./tonsillit.& otit.media caus.by suscept.organ.  fts.old.than 1 wk: 3-6 mg /kg/day in 3 equal.div. dos.8 hrly or in 2   nesaem./calcaem.& kalaem., resp. depress., musc.twitch., musc.
       (S4) TABS, [P/S] 31/20.1.1/0045.  equal dos.12 hrly. Neonates & infts.less than 1 wk: 6 mg/kg/day   paralys., headache.
                                                                                th
       832278-009: 500 mg, 3, R213,96  in 2 equal.div. dos.12 hrly. Dos.interv.poss.vary depend.on pt. condit.  Special precautions: Poss. 8  foet.cran.nerve damage if used in
       Dosage: Chlamyd.trachomat./haemophilus ducreyi/non-  Contraindications: Safety in pregn.& lactat. not est., concom.  pregn., avoid concurr./sequent. use of other aminoglycosid.& other
       multiresist.N.gonorrh: Adults: 1 g as sngl.dos.  ethacryn.acid/ furosemide/ other potent.ototox.agents/ neuro-  potent. neurotox. &/nephrotox. antibiot.esp.streptomycin/ neomy-
       Other indicat: Adults & childr.over 45 kg: Total dos.1,5 g given as   musc. block.agents.  cin /kanamycin/gentamycin/cefaloridine/ paronomycin/ viomycin/
       500 mg dly x3 days.           Side effects: Ototoxic., nephrotox., hypersens./ anaphylact.reacts.,   polymixin B/colistin/ vancomycin/amikacin, caref.monit.of pts.on
       (S4) SUSP, [P/S] 27/20.1.1/0279. 200 mg/5 ml.  aminoglycos.cross-sens., bld. dyscras., purpura, GI disturbs., sto-  high dos. lev./prolong.treatm.esp.infts.& elderly, monit. obese pts./
       830720-006: 15 ml, R129,71    matit., endotox. shock, electrol.disturbs., eye disords.foll.intra-ocul.   cyst.fibros./known or susp.ren.funct. impairm., concom.neuromusc.
       830720-014: 30 ml, R259,41    inj., neuromusc.blockade     block.& nephro-/ ototoxic.agents, anti-emet.poss.mask.ototox.
       Dosage: Presentat.suitable for childr.und.45 kg.  Special precautions: Imp.ren.funct., myasth. grav., parkinsonism/  sympt., per.peak & trough ser.lev.monit.esp.in ren. impairm., oto-
       Childr.1 yr.& older: Total dos: 30 mg/kg giv.as sngl.dly.dos.of 10 mg/  condits.charact.by musc. weakn., incr.ototoxic.risk with imp.hepat.or   toxic./nephrotoxic.risk fact.
       kg x3 days as follows: &lt;15 kg: 10 mg/kg once dly x3 days. 15-25 kg:   audit. funct./bacteraem./fev./loud nois.expos., nephrotoxic. risk with   Drug interactions: Poss.antagon.pyridostigmine eff.on skelet.musc.
       5 ml once dly x3 days. 26-35 kg: 7,5 ml once dly x3 days. 36-45 kg:   vol.deplet./hypotens./liv. dis./female, other potent.ototox.& nephro-  in myasth.grav.pts., enhanc.eff. of neuromusc. block. agents result.in
       10 ml once dly x3 days. &gt;45 kg: as per adults.  tox. subst., monit.ser.lev., monit.ren./audit./vestib. funct. in case of   skelet.musc. weakn.& poss. resp.depress./paralys.
       (S4) IV POWD.INFUS, 36/20.1.1/0190. 500 mg  high dos.lev.or extend.treatm.per.
       Indications: Community acquir.suscept. pneumon. infects.incl.Le-  Drug interactions: Cross-sens.with neomycin & kanamycin, diuret.
                                     such as ethacryn.acid & furosemide may result in ototox., cephalo-
       gionella pneumophila.requir.init.IV ther.  sporin may potent nephrotoxic., poss. resp.depress./ musc. paralys. 18.4  Tetracyclines
       702721-001: 100 mg/ml, 10 ml sngl.dos., R320,85
       Dosage: Reconstit.& admin.IV infus.over not less than 1 hr. Conc.  with concom.neuromusc.block. agents.
       of 1 mg/ml infus.over 3 hrs./2 mg/ ml conc.infus.over 1 hr.Do not   KANAMYCIN 1 g BIOTECH, Biotech [P/S]  CYCLIMYCIN, (Aspen Pharmacare: Pharma) Pharmacare [P/S]
       admin.as bolus/IMI            Kanamycin sulph.             Minocycline HCl equiv.to minocycline
       Adults: 500 mg IV as sngl.dos.x2 days. Convert.to oral ther.in ac-  Indications: G-ve infect.where less toxic antibiotics are unsuit.  Indications: Suscept.organ.infects., gonorrh., syphil.& anthrax
       cord.with clinic.respons.as sngl.dly. dos.of 500 mg to compl.7-10   (S4) INJ. 44/20.1.1/0316  where penicill.allerg.pres., acne-adjunct.
       day course.                   717443-001: 1 g/3 ml, 10 vials, R214,50  (S4) CAPS. W/20.1.1/442, 443.
       Contraindications: Sens.to erythromyc./any macrolide/ketolide   Dosage: IMI admin.usual.  788287-001: 50 mg, 60, R243,02
       antibiot., concom.ergot. derivat., sev.hepat.dis., safety & effic.in   Adults: 15 mg/kg bm/day in 2-3 div.dos. Max. 1,5 g dly.& 15 g over   788295-012: 100 mg, 100, R1 185,61
       pregn./ lactat.& childr.und.1 yr not est., safety & effic.of IV presen-  st  Dosage: Adults: 200 mg init.,then 100 mg 12 hrly. Childr: Init.4 mg/
       tat.in childr.not est         treatm.per. Neonates: 7,5 mg/kg bm/day for 1  3 days of life in   kg follow.by 2 mg/kg 12 hrly.
                                     2 -4 div. dos. Childr: 5-15 mg/kg bm dly. in div.dos. Max: 600 mg
       Side effects: GI disturbs., hear.imp., interstit. nephrit., ac.ren.fail.,   dly.x6 days.  Acne: Init. 50-100 mg 2xdly. Maint: 50 mg 2xdly.
       abnorm.liv.funct.incl. cholestat. jaund.& hepatit., reduc.neutrophil.   Contraindications: Intest.disinfect.when obstruct. is pres., trivial   Contraindications: Pregn.& lactat., childr.und.12 yrs, potent.
       counts, chest pain, malaena, vaginit., CNS effs., convuls., palpit.&   infect., imp.hear.  hepatotox.medic.
       arrythm., asthen./parathes., taste disturbs., allerg.reacts.incl.ar-  Side effects: N&V, diarrh., staph. anterocolit., skin rash, fev., head-  Side effects: GI disturbs., non-suscept.organ. overgrowth, tooth
       thralg., angioed., oed., ser.skin reacts.incl.erythema multiforme/  ache, paraesth., ren.disturbs., deafn., neurotox.reacts., neuromusc.  discol., enamel hypoplas.& retard. bone growth in childr.und.12/
       Stev. John.syndr./tox.epiderm. necrolys., photosens.& anaphylax.,   block, resp. depress., foll.intra-periton.applic.  foetus, incr. IC-press.& bulg.fontanel.in infts., bld.dyscras., vit.def-
       fatig., nephrit., vertigo, bld.dyscras., superinfect., loc.reacts.with IV   Special precautions: Imp.ren.funct., if tinnit./ dizz. occur withdr.  ic., allerg.reacts., photosens., poss.neg. nitrog. balance in elderly,
       infus., psychot.disords., QT prolongat., torsade de pointes, hypotens.,   immed., concom.neuromusc. block. agents, anticoags., anti-emet.,   pseudotumour cerebri
       abnorm.vis., malaise.         other ototox. agents.        Special precautions: Imp.liv.funct., myasth.grav. sympt. poss.
       Special precautions: Admin.1 hr.bef.or 2 hrs. aft.antacids., poss.  aggrav.
       pseudomembr.colit., sev.ren. impairm., concom.cyclospor.& terfena-  PHARMA-Q GENTAMICIN INJECTION, Pharma-Q [P/S]  Drug interactions: Poss.reduc.anticoag.dos., Ca, Mg, Al & iron salts
       dine., poss. rais.digox.lev., monit.prothromb.time with concom. war-  Gentamicin sulph.equiv.to gentamicin.  decr.absorpt., poss.antagon.in act.with concom.penicill.
       far., prolong.card.repolarisat.& QT interv.assoc. with card.arrhythm.&   Indications: Sens.UTI, syst.infects., bone & soft-tiss.infects., in-  DOXYCYCLINE BIOTECH 100 mg, Biotech [P/S]
       torsade de pointes developm., fruct.intol./gluc.-galact. malabsorpt./   fect.burns, RTI.  Doxycyline hyclate equiv.to doxycycl.
       sucrase-isomaltase insuffic.for prolong.-rel.susp., prolong.-rel.susp.  (S4) INJ, 31.20.1.1/0441, 0442, 0443   Indications: Suscept.U & LRTI’s /GUT/ acne/ opthalm./intest.in-
       cont.Na, concom.meds.with potent.to prolong.QT interv., concom.  899132-002: 20 mg/2 ml, 10x2 ml amps, R116,64  fects./ Rickettsia/brucellos./ tularaem./actinomycos./Lyme dis./
       cyclospor., monit.for advers.effs.with nelfinavir.  899135-005: 40 mg/1 ml, 10x1 ml amps R130,56  yaws/relaps. fev./leptospiros.
       Drug interactions: Some macrolide antibiot.imp. digox.microb.  899139-002: 80 mg/2 ml, 10x2 ml, amps, R48,32  (S4) TABS, 31/20.1.1/0425
       metabol.in gut with poss.rais. digox. lev., potent.anticoagulat.  Dosage: Usual.admin.IM. IV admin.in spec. circumst. only. Infus.  722844-001: 100 mg, 100, R53,59
       with coumar.oral anticoag., cyclospor.C max & AUC 0-5 elev., nelfina-  over per.up to 2 hrs.  Dosage: Admin.with adeq.liq.while pt.in upright pos. 1 hr bef./
       vir incr.ser.conc.            Same dos.may be admin.IM/IV. Plasma conc.not to exceed 10 µg/  2 hrs.aft.meals.
                                     ml.Monit.dos.with serum peak & through lev.Treatm.per.limit.  Usual.100 mg 2x dly.on 1  day then 100 mg dly.
                                                                             st
                                     to 7-10 days.                Acne: Adults: 50 mg 2x dly.
       18.3   Aminoglycosides        Adults with norm.ren.funct: 3-5 mg/kg/day in 3 equal dos.(8 hrly)  Contraindications: Ren.impairm., childr.und. 12 yrs., SLE, pregn.&
                                                                  lactat.
                                     Childr: 3-5 mg/kg/day admin.in 3 equal.div.dos. 8 hrly depend.on sev.
                                     Neonates & infts.less than 1 wk: 6 mg/kg/day in 2 div.dos.12 hrly  Side effects: Tooth /nail discol., GI disturbs. incl. oesophag.ulcer.
       AMIKACIN FRESENIUS, Fresenius Kabi [P/S]  Infts.old.than one wk: 6 mg/kg/day in 2 equal dos.12 hrly or 3   when oral preps.taken with insuffic. water/in recumb.posit., incr.
       Amikacin sulph.               equal.div.dos.8 hrly.        uraem. severity/ hepatotoxic.in pts.with ren.dis.giv.high dos., bld.
       Indications: Serious nosocomial G-ve bacillary infects.  Contraindications: Myasth.grav., pregn.& lactat.  dyscras., vit.defic., allerg./hypersens. reacts. incl.angioneurot.oed./</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page273.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page269.html">269</a>&nbsp;&nbsp;&nbsp;<a href="page270.html">270</a>&nbsp;&nbsp;&nbsp;<a href="page271.html">271</a>&nbsp;&nbsp;&nbsp;<a href="page272.html">272</a>&nbsp;&nbsp;&nbsp;<a href="page273.html">273</a>&nbsp;&nbsp;&nbsp;<a href="page274.html">274</a>&nbsp;&nbsp;&nbsp;<a href="page275.html">275</a>&nbsp;&nbsp;&nbsp;<a href="page276.html">276</a>&nbsp;&nbsp;&nbsp;<a href="page277.html">277</a>&nbsp;&nbsp;&nbsp;<a href="page278.html">278</a>&nbsp;&nbsp;&nbsp;<a href="page279.html">279</a>
             </td>
             <td width="35%"><a href="page275.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page275.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
